Attention Deficit Hyperactivity Disorder - A Pre Audit Study of the Pattern of Drug Treatment in a Specialist Community Child and Adolescent Mental Health Service in the UK


  • Jibowu Olubokun South West London & St George’s University of London Mental Health Trust, Cricket Green Polyclinic, 4 Birches House, Birches Close. Mitcham, Surrey CR4 4LQ, UK



Audit, Adhd, Treatment, Psycho stimulants.


Attention deficit hyperactivity disorder (ADHD) is a neuro developmental disorder and a common disorder of childhood with functional impairments and a significant personal, family and psychosocial burden. This is a pre audit study of children and young people with ADHD who were referred to the Specialist Community Child and Adolescent Mental Health service in Calderdale, Halifax in East Yorkshire. The main aim of the pre audit study was to determine and study the pattern of drug treatment with psycho stimulant medication in the service as well to study the socio-demographic characteristics of the children and young people referred. This was a cross - sectional study. Twenty cases were randomly selected from the available records and data was extracted directly from the medical records using data sheets designed for the pre-audit study. Males constituted 85% of the study sample and Females 15%. Age group 9-12 constituted 65% of the sample. The modified release preparation of Ritalin was more commonly prescribed than the immediate release preparation. Some practical advantages and limitations of brands are highlighted. The initial findings are useful and would help to modify the data sheet for improved quality and help to set the ‘audit standards’ for the main audit study. This has clinical governance implications in terms of delivering the most expedient quality care in a Child and Adolescent Mental Health Service.


American Psychiatric Association. Diagnostic and Statistical Manual(DSM 5). 2013. 5th ed. New York, APA DOI:

Audit. 2008: ‘’How to do it in practice’’. BMJ, 336: 1241 DOI:

Coghill D, Soutullo C, D' Aubuisson C, Preuss U, Lindback T, Silverberg M and Buitelaar J. 2008. ‘’Impact of attention deficit hyperactivity disorder on patient and family: result from an European survey’’. Child Adolescent Psychiatry Mental Health, 2:31. DOI:

Garralda ME, Yates P and Higginson I. 2000. ‘’Child and Adolescent Mental Health Service use HonosCA as an outcome measure’’. Brit J Psych, 177; 52-58. DOI: and Adolescent.aspx

McBurnette K and Pfiffner LJ. 2009. ‘’The treatment of aggressive ADHD in Children and Adolescents, conceptualisation and treatment of Co morbid behaviour disorders’’. Post grad Med 121 (96): 158-65. DOI:

National Institute for Health and Clinical Excellence: Quick Reference Guide. 2008 - Attention deficit Hyperactivity Disorder. NICE Clinical Guideline 72, London.

Polanczyk G, De Lima MS, Horta BL, Biederman J, Rhode LA. 2007. ‘’The world wide prevalence of ADHD: a systematic review and metagression analysis’’. Am J Psychiatry, 164 (6): 942-8 DOI:

Sally G and Donaldson LJ. 1998. ‘’Clinical Governance and the drive for Quality Improvement in the New NHS in England’’. BMJ, 317: 61-65. DOI:

Word Health Organisation. The International Classification of Diseases (ICD10) 1992. 10th Ed. Geneva, WHO. sheet/concerta tab.pdf




How to Cite

Olubokun, J. (2015). Attention Deficit Hyperactivity Disorder - A Pre Audit Study of the Pattern of Drug Treatment in a Specialist Community Child and Adolescent Mental Health Service in the UK. International Journal of Criminology and Sociology, 4, 136–140.